DMP1
Basic information
Region (hg38): 4:87650280-87664361
Links
Phenotypes
GenCC
Source:
- hypophosphatemic rickets, autosomal recessive, 1 (Definitive), mode of inheritance: AR
- hypophosphatemic rickets, autosomal recessive, 1 (Moderate), mode of inheritance: AR
- hypophosphatemic rickets, autosomal recessive, 1 (Strong), mode of inheritance: AR
- autosomal recessive hypophosphatemic rickets (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hypophosphatemic rickets, autosomal recessive 1 | AR | Endocrine | Supplementation (eg, with phosphate and vitamin D) can be beneficial | Endocrine | 17033621; 17033625 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (162 variants)
- Hypophosphatemic_rickets,_autosomal_recessive,_1 (94 variants)
- Inborn_genetic_diseases (52 variants)
- not_specified (14 variants)
- DMP1-related_disorder (7 variants)
- Hypophosphatemic_rickets (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DMP1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004407.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 50 | 51 | ||||
| missense | 146 | 15 | 164 | |||
| nonsense | 7 | |||||
| start loss | 2 | 2 | ||||
| frameshift | 5 | |||||
| splice donor/acceptor (+/-2bp) | 5 | |||||
| Total | 10 | 7 | 149 | 65 | 3 |
Highest pathogenic variant AF is 0.0001295104
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DMP1 | protein_coding | protein_coding | ENST00000339673 | 5 | 14055 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.49e-7 | 0.628 | 125655 | 0 | 93 | 125748 | 0.000370 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.273 | 255 | 268 | 0.953 | 0.0000134 | 3519 |
| Missense in Polyphen | 84 | 93.3 | 0.90032 | 1260 | ||
| Synonymous | 0.466 | 94 | 99.9 | 0.941 | 0.00000590 | 852 |
| Loss of Function | 1.11 | 13 | 18.1 | 0.719 | 7.84e-7 | 246 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000380 | 0.000380 |
| Ashkenazi Jewish | 0.00466 | 0.00467 |
| East Asian | 0.000218 | 0.000217 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000194 | 0.000193 |
| Middle Eastern | 0.000218 | 0.000217 |
| South Asian | 0.0000980 | 0.0000980 |
| Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May have a dual function during osteoblast differentiation. In the nucleus of undifferentiated osteoblasts, unphosphorylated form acts as a transcriptional component for activation of osteoblast-specific genes like osteocalcin. During the osteoblast to osteocyte transition phase it is phosphorylated and exported into the extracellular matrix, where it regulates nucleation of hydroxyapatite. {ECO:0000269|PubMed:12615915}.;
- Disease
- DISEASE: Hypophosphatemic rickets, autosomal recessive, 1 (ARHR1) [MIM:241520]: A hereditary form of hypophosphatemic rickets, a disorder of proximal renal tubule function that causes phosphate loss, hypophosphatemia and skeletal deformities, including rickets and osteomalacia unresponsive to vitamin D. Symptoms are bone pain, fractures and growth abnormalities. {ECO:0000269|PubMed:17033621, ECO:0000269|PubMed:17033625}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Role of Osx and miRNAs in tooth development;Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Extracellular matrix organization;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);ECM proteoglycans;AP-1 transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.794
- rvis_EVS
- 0.51
- rvis_percentile_EVS
- 80.3
Haploinsufficiency Scores
- pHI
- 0.593
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0337
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dmp1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- ossification;positive regulation of cell-substrate adhesion;extracellular matrix organization;biomineral tissue development;post-translational protein modification;cellular protein metabolic process;regulation of enamel mineralization
- Cellular component
- extracellular region;nucleus;endoplasmic reticulum lumen;extracellular matrix
- Molecular function
- integrin binding;calcium ion binding;extracellular matrix binding